BIO-MEDISINSK INNOVASJON and GLAXO GROUP LIMITED have reached a cooperative agreement on development and commercialisation of a new drug for treatment of heart failure.
See press release (in Norwegian): http://www.bmioslo.no/releaseNorsk.html
See also article in Aftenposten: http://www.aftenposten.no/nyheter/okonomi/article1121987.ece.
Webmaster Fredrik Swift